β2-agonist abuse in food producing animals: Use of in vitro liver preparations to assess biotransformation and potential target residues for surveillance

Xenobiotica

Volumn 29, Issue 5, 1999, Pages 483-497

  Sauer, M J ^a   Dave, M ^a   Lake, B G ^b   Manchee, G R ^c   Howells, L C ^a   Coldham, N G ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b BIBRA INTERNATIONAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN; ARYLSULFATASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA GLUCURONIDASE; CLENBUTEROL; SALBUTAMOL; SALMETEROL; 7-ETHOXYCOUMARIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COUMARIN DERIVATIVE; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CATTLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; DRUG SURVEILLANCE PROGRAM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MASS SPECTROMETRY; MONOLAYER CULTURE; NONHUMAN; XENOBIOTIC METABOLISM; ANIMAL; CHEMISTRY; CYTOLOGY; FOOD CONTAMINATION; FOOD POISONING; LIVER; MALE; MEAT; METABOLISM;

ANIMALIA; BOS TAURUS; BOVINAE; HELIX POMATIA;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; BIOTRANSFORMATION; CATTLE; CLENBUTEROL; COUMARINS; FOOD CONTAMINATION; FOOD POISONING; LIVER; MALE; MEAT PRODUCTS; MICROSOMES, LIVER;

EID: 0032587963     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238498     Document Type: Article

References (42)

1. BIANCOTTO, G., ANGELETTI, R., PIRO, R. D. M., FAVRETTO, D. and TRALDI, P., 1997, Ion trap high-performance liquid chromatography/multiple mass spectrometry in the determination of beta-agonists in bovine urines. Journal of Mass Spectrometry, 32, 781-784.
2. BOPPANA, V. K., LYNN, R. A. and ZIEMNIAK, J. A., 1989, Immobilized sulphatase: beta-glucuronidase enzymes for the qualitative and quantitative analysis of drug conjugates. Journal of Pharmaceutical Sciences, 127, 127-131.
3. CHEN, T. H., KUSLIKIS, B. I. and BRASELTON, W. E., 1989, Hydroxylation of 4,4′-methylenebis(2-chloroaniline) by canine, guinea-pig, and rat liver microsomes. Drug Metabolism and Disposition, 17, 406-413.
4. COLDHAM, N. G., MOORE, A. S., DAVE, M., GRAHAM, P. J., SIVAPATHASUNDARAM, S., LAKE, B. G. and SAUER, M. J., 1995, Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metabolism and Disposition, 23, 501-505.
5. CONOLLY, M. E., DAVIES, D. S., DOLLERY, C. T., MORGAN, C. D., PATERSON, J. W. and SANDLER, M., 1972, Metabolism of isoprenaline in dog and man. British Journal of Pharmacology, 46, 458-472
6. Conway, W. D., Singhvi, S. M., Gibaldi, M. and Boyes, R. N., 1973, The effect of route of administration on the metabolic fate of terbutaline in the rat. Xenobiotica, 3, 813-821.
7. CONWAY, W. D., MINATOYA, H., LANDS, A. M. and SHEKOSKY, J. M., 1968, Absorption and elimination profile of isoproteranol III. Journal of Pharmaceutical Sciences, 57, 1135-1141.
8. DAVIES, D. S., GEORGE, C. F., BLACKWELL, E., CONOLLY, M. E. and DOLLERY, C. T., 1974, Metabolism of terbutaline in man and dog. British Journal of Clinical Pharmacology, 1, 129-136.
9. DENGLER, H. J. and HENGSTMANN, J. H., 1976, Metabolism and pharmacokinetics of orciprenaline in various animal species and man. Archives Internationales de Pharmacodynamie et de Therapie, 233, 71-87.
10. GEORGE, C. F., 1981, Drug metabolism by the gastrointestinal mucosa. Clinical Pharmacokinetics, 6, 259-274.
11. GUENTERT, T. W., BUSKIN, J. A. and GALEAZZI, R. L., 1984, Single dose pharmacokinetics of mabuterol in man. Arzneimittel-Forschung/Drug Research, 34, 1691-1696.
12. GUPTA, R. and DANI, H. M., 1989, In vitro formation of organ-specific ultimate carcinogens of 4-dimethylaminoazobenzene and urethane by microsomes. Toxicology Letters, 45, 49-53.
13. HOOGENBOOM, L. A. P., 1991, The use of pig hepatocytes for biotransformation and toxicity studies. PhD thesis, RIKILT, Wageningen.
14. HOOGENBOOM, L. A. P., HESSE, S. E., BERGHMANS, M. C. J. and KINPER, H. A., 1990, The use of primary culture of pig hepatocytes for biotransformation studies of veterinary drugs. In F. Simon, P. Lees and G. Senijen (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals (Hungary: University of Veterinary Science), pp 467-479.
15. 2-stimulant. II: Urinary metabolites of mabuterol in rats and their pharmacological effects. Arzneimittel-Forschung/Drug Research, 34, 1668-1679.
16. KECK, J., KRUGER, G., NOLL, K. and MACHLEIDT, H., 1972, Synthesen von neuen amino-halogen-substituierten phenyl-aminoathanolen. Arzneimittel-Forschung/Drug Research, 22, 861-869.
17. KOPITAR, Z., ZIMMER, A., BINDER, B., FOLDENNAUER, K., HEINTZ, V., KASCHKE, S. and SCHMAUS, H., 1976, Pharmakokinetik und Metabolitenmuster von Clenbuterol bei der ratte. Arzneimittel-Forschung/Drug Research, 26, 1435-1441.
18. 2 sympathomimetics in isolated rat intestinal epithelial cells. Drug Metabolism and Disposition, 13, 232-238.
19. LAKE, B. G., 1987, Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In K. Snell and B. Mullock (eds), Biochemical Toxicology (Oxford: IRL Press), pp. 183-209.
20. LAKE, B. G., SAUER, M. J., ESCLANGON, F., BEAMAND, J. A., PRICE, R. J. and WALTERS, D. G., 1995, Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes. Xenobiotica, 25, 133-141.
21. MANCHEE, G. R., BARROW, A., KULKARNI, S., PALMER, E., OXFORD, J., COLTHUP, P. V., MACONOCHIE, J. G. and TARBIT, M. H., 1993, Disposition of salmeterol xinafoate in laboratory animals and humans. Drug Metabolism and Disposition, 21, 1022-1028.
22. 3H: a new bronchodilator, in rat, rabbit, dog. European Journal of Pharmacology, 14, 183-199.
23. MARTINEZ-NAVARRO, J. F., 1990, Food poisoning related to consumption of illicit β-agonist in liver. Lancet, 336, 1311.
24. MENNES, W. C., BLAAUBOER, B. J. and VAN HOLSTEIJN, C. W. M., 1988, Biotransformation and cytotoxicity studies in primary hepatocyte cultures derived from different mammalian species. In A. Guillouzo (ed.), Liver Cells and Drugs. Colloque INSERM, vol. 164 (London: Libby), pp. 351-355.
25. 3H) isoprenaline in man and dog. Proceedings of the Biochemical Society, 494th Meeting, p. 8.
26. MORGAN, D. J., 1990, Clinical pharmacokinetics of β-agonist. Clinical Pharmacokinetics, 18, 270-294.
27. PARRISH, A. R., GANDOLPHI, A. J. and BRENDEL, K., 1995, Precision-cut tissue slices: Applications in pharmacology and toxicology. Life Sciences, 57, 1887-1901.
28. PERSSON, K. and PERSSON, K., 1972, The metabolism of terbutaline in vivo by rat and human O-methyltransferases and monoamine oxidases. Xenobiotica, 2, 375-382.
29. POOL, B. L., BRENDLER, S. Y., LIEGIBEL, U. M., TOMPA, A. and SCHMEZER, P., 1990, Employment of adult mammalian primary cells in toxicology: in vivo and in vitro genotoxic effects of environmentally significant N-nitroso-dialkylamines in cells of the liver, lung and kidney. Environmental and Molecular Mutagens, 5, 24-35.
30. PULCE, C., LAMAISON, D., KECK, G., BOSTVIRONNOIS, C., NICOLAS, J. and DESCOTES, J., 1991, Collective human poisonings by clenbuterol residues in veal liver. Veterinary and Human Toxicology, 33, 480-481.
31. ROMINGER, K. L. and POLLMANN, W., 1972, Vergleichende pharmakokinetik von Fenoterol-Hydrobormid bei Ratte Hund und Mensch. Arzneimittel-Forschung/Drug Research, 22, 1190-1196.
32. SALLERAS, L., DOMINGUEZ, A., MATA, E., TABERNER, J. L., MORO, I. and SALVA, P., 1995, Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Report, 110, 338-342.
33. SAUER, M. J., PICKETT, R. J. H., LIMER, S. and DIXON, S. N., 1995, Distribution and elimination of clenbuterol in tissues and fluids of calves following prolonged oral administration at a growth-promoting dose. Journal of Veterinary Pharmacology and Therapeutics, 18, 81-86.
34. SCHMID, J., PROX, A., ZIMMER, A., KECK, J. and KASCHKE, S., 1990, Biotransformation of clenbuterol. Fresenius Journal of Analytical Chemistry, 337, 121.
35. SHIMIZU, T., MORI, H., TABUSA, E., MORITA, S., MIYAMOTO, G., YASUDA, Y. and NAKAGAWA, K., 1978, The metabolism of a bronchodilator procaterol. HCl in the rat in vitro and in vivo. Xenobiotica, 8, 349-358.
36. SHULL, L. R., KIRSCH, D. G., LOHSE, C. K., CARLSON, G. P., DODDY, L. K. and WISNIEWSKI, J. A., 1986, Xenobiotic metabolism in suspensions and primary cultures of isolated hepatocytes prepared from the caudate process of the bovine liver. American Journal of Veterinary Research, 47, 2043-2052.
37. SUOLINNA, E.-M. and WINBERG, A.-M., 1985, 7-Ethoxycoumarin-O-deethylation and methyl-umbelliferone conjugation in isolated fetal and adult bovine hepatocytes. Drug Metabolism and Disposition, 13, 722-724.
38. TANABE, H., KAGEYAMA, H., KUBO, J. and NARUCHI, T., 1984, Metabolic fate of clenbuterol (NAB 365) (III). Metabolism in rats and dogs. Iyakuhin Kenkyu, 15, 467-476.
39. YAMAMOTO, I., IWATA, K. and NAKASHIMA, M., 1985, Pharmacokinetics of plasma and urine clenbuterol in man, rat and rabbit. Journal of Pharmacobiodynamics, 8, 385-391.
40. ZALCO, D., DEBRAUWER, L., BORIES, G. and TULLIEZ, J., 1997, Evidence for a new major metabolic pathway of clenbuterol involving in vivo formation of an N-hydroxylarylamine. Chemical and Research Toxicology, 10, 197-204.
41. ZIMMER, A. and BUCHELER, A., 1976, Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen. Arzneimittel Forschung/Drug Research, 26, 1446-1450.
42. ZIMMER, A., BUCHELER, A. and KASCHKE, S., 1976, Pharmakokinetik und Metabolitenmuster von Clenbuterol beim Kaninchen und beim Hund. Arzneimittel Forschung/Drug Research, 26, 1442-1445.